Peristeen Bowel Irrigation System in Cauda Equina
Launched by UNIVERSITY OF MANITOBA · Feb 1, 2013
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
People with spinal cord injury (SCI) often have severe problems with management of bowel function, including incontinence, impaction, lengthy bowel routines and extremely slow transit times.The anal irrigation system is a recently available system to help patients with bowel dysfunction empty their bowels by using pulse water irrigation. The system consists of a rectal balloon catheter, manual pump and water container.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female \>18 years or older
- * Cauda equina spinal injury at least 12 months previously, with lower motor neuron bowel dysfunction and at least one of the following symptoms:
- • Spending 30 minutes or more attempting to defecate each day or every second day
- • Episodes of fecal incontinence once or more per month
- • Abdominal discomfort before or during defecation
- Exclusion Criteria:
- • Coexisting major unresolved physical problems due to the injury
- • Performance of transanal irrigation on a regular basis
- • Evidence of bowel obstruction or active inflammatory bowel disease
- • History of cerebral palsy, stroke, multiple sclerosis or diabetic polyneuropathy
- • Previous colorectal or perineal surgery(excluding minor surgery such as hemorrhoidectomy)
- • Pregnancy or lactation
- • Immunosuppression
- • Prior implant for sacral nerve stimulation
About University Of Manitoba
The University of Manitoba, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive expertise in medical research, public health, and community engagement to conduct rigorous and ethical clinical studies. The institution aims to translate scientific findings into practical applications that enhance patient care and improve health outcomes. Committed to fostering a culture of excellence and integrity, the University of Manitoba prioritizes participant safety and scientific validity in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winnipeg, Manitoba, Canada
Patients applied
Trial Officials
Karen Ethans, MD
Principal Investigator
University of Manitoba
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials